Qube Research & Technologies (QRT)’s Bellicum Pharmaceuticals BLCM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLCM
BBA
Qube Research & Technologies (QRT)'s BLCM Position: Q1 2021 in Review
Qube Research & Technologies (QRT) sold out of Bellicum Pharmaceuticals (BLCM) in Q1 2021, closing a stake of 15,760 shares — an estimated $56K sold.
Qube Research & Technologies (QRT) first reported a position in BLCM in Q3 2020 and held it in 2 quarters. The position peaked at $272K in Q3 2020. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2021.
- Qube Research & Technologies (QRT) reported no remaining Bellicum Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 15,760 Bellicum Pharmaceuticals shares in Q1 2021, an estimated $56K.
- Qube Research & Technologies (QRT) first reported a position in Bellicum Pharmaceuticals in Q3 2020 and held it in 2 quarters.
- Qube Research & Technologies (QRT)'s Bellicum Pharmaceuticals position peaked at $272K in Q3 2020.
- 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals as of Q1 2021.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.